ArticleFrontiers in immunology2025

Breaking barriers: harnessing hypofractionated radiotherapy to transform outcomes in low tumor mutation burden stage III non-small cell lung cancer - a retrospective study.

Jingyun Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.